Skip to content

13F-HR filed by EMORY UNIVERSITY

EMORY UNIVERSITY filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-15, with 10 holding rows worth $52,879,000.

Accession
0001377635-15-000003
Filed
2015-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 10 entries on the cover page, a total value of $52,879,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $52,879,000 with VALUE read as thousands by filing date, 13F file number 028-16101. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VWO922042858SHS1,058,781$43,272,000thousands by filing date
ANACOR PHARMACEUTICALS INC032420101COM23,325$1,349,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM9,715$1,211,000thousands by filing date
INCYTE CORP COM45337C102Stock12,729$1,167,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM45,261$1,049,000thousands by filing date
SEATTLE GENETICS INC812578102COM29,535$1,044,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM32,167$983,000thousands by filing date
SYNAGEVA BIOPHARMA CORP87159A103COM9,854$961,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM29,356$957,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock98,161$886,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001377635-15-000003this filing2015-05-15acceptance time not in the bulk data set